Page last updated: 2024-09-03

293b cpd and Myocardial Infarction

293b cpd has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, A; Becker, R; Freigang, KD; Kraft, P; Kuebler, W; Schoels, W; Senges, JC; Voss, F1

Other Studies

1 other study(ies) available for 293b cpd and Myocardial Infarction

ArticleYear
Electrophysiologic effects of the new I(Ks)-blocking agent chromanol 293b in the postinfarction canine heart. Preserved positive use-dependence and preferential prolongation of refractoriness in the infarct zone.
    Basic research in cardiology, 2000, Volume: 95, Issue:4

    Topics: Animals; Chromans; Dogs; Heart; Myocardial Infarction; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides

2000